WallStreetZenWallStreetZen

NASDAQ: NBSE
Neubase Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their NBSE stock forecasts and price targets.

Forecast return on equity

Is NBSE forecast to generate an efficient return?
Company
-955.09%
Industry
18.39%
Market
28.92%
NBSE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NBSE forecast to generate an efficient return on assets?
Company
-468.62%
Industry
9.3%
NBSE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NBSE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NBSE$0.90N/AN/A
ONCO$0.18N/AN/A
AVTX$4.42N/AN/A
PCSA$2.46N/AN/A
OGEN$1.43N/AN/A

Neubase Therapeutics Stock Forecast FAQ

What is NBSE's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: NBSE) forecast ROE is -955.09%, which is considered weak.

If you're new to stock investing, here's how to buy Neubase Therapeutics stock.

What is NBSE's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: NBSE) forecast ROA is -468.62%, which is lower than the forecast US Biotechnology industry average of 9.3%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.